Litchfield Caroline — SEC Form 4 filings
SEC reporting owner CIK 1854928. 12 Form 4 filings on record with FilingPulse; latest filed 2026-05-07.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-24 to 2026-05-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 80,288 shares, $9,828,832 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 41,997 shares @ $119.61 ($5,023,312) in Merck & Co., Inc., filed 2026-02-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Merck & Co., Inc. (MRK) | EVP & CFO | 9 | — | 2 legs · 80,288 sh · $9,828,832 | 15 |
| VERIZON COMMUNICATIONS INC (VZ) | Director | 3 | — | — | 3 |
Form 4 filings — Litchfield Caroline
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-07 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 15,908 (derivative) @ $0 · Grant/award (A): 46,566 (derivative) @ $0 | EDGAR |
| 2026-05-01 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 3,935 @ $110.03 · Tax withholding (F): 1,938 @ $110.03 · Option exercise (M): 3,935 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | VERIZON COMMUNICATIONS INC (VZ) | Grant/award (A): 5,062 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 41,997 @ $53.06 · Sale (S): 41,997 @ $119.61 · Option exercise (M): 41,997 (derivative) @ $0 | EDGAR |
| 2026-01-28 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 15,852 @ $107.40 | EDGAR |
| 2025-05-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 11,805 (derivative) @ $0 · Grant/award (A): 53,735 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | VERIZON COMMUNICATIONS INC (VZ) | Grant/award (A): 4,748 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 23,432 @ $97.94 | EDGAR |
| 2024-10-03 | 4 | VERIZON COMMUNICATIONS INC (VZ) | Grant/award (A): 1,161 (derivative) @ $45.21 | EDGAR |
| 2024-05-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 49,805 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 38,291 @ $58.08 · Sale (S): 38,291 @ $125.50 · Option exercise (M): 38,291 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 19,208 @ $119.43 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1854928 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →